Nothing Special   »   [go: up one dir, main page]

FR2340310A1 - Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant - Google Patents

Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
FR2340310A1
FR2340310A1 FR7703442A FR7703442A FR2340310A1 FR 2340310 A1 FR2340310 A1 FR 2340310A1 FR 7703442 A FR7703442 A FR 7703442A FR 7703442 A FR7703442 A FR 7703442A FR 2340310 A1 FR2340310 A1 FR 2340310A1
Authority
FR
France
Prior art keywords
hydrazinophtalazines
substituted
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703442A
Other languages
English (en)
Other versions
FR2340310B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2340310A1 publication Critical patent/FR2340310A1/fr
Application granted granted Critical
Publication of FR2340310B1 publication Critical patent/FR2340310B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7703442A 1976-02-09 1977-02-08 Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant Granted FR2340310A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4896/76A GB1567907A (en) 1976-02-09 1976-02-09 (3-amino-2-hydroxypropoxy)-1-hydrazonophthalazines and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FR2340310A1 true FR2340310A1 (fr) 1977-09-02
FR2340310B1 FR2340310B1 (fr) 1980-03-07

Family

ID=9785918

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703442A Granted FR2340310A1 (fr) 1976-02-09 1977-02-08 Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant

Country Status (6)

Country Link
US (1) US4093725A (fr)
JP (1) JPS5297986A (fr)
BE (1) BE851237A (fr)
DE (1) DE2705414A1 (fr)
FR (1) FR2340310A1 (fr)
GB (1) GB1567907A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442094A (en) * 1980-12-23 1984-04-10 Merck & Co., Inc. (3-Aralkylamino-2-or-propoxy)heterocyclic compounds
US4331679A (en) * 1980-12-23 1982-05-25 Merck Sharp & Dohme (I.A.) Corp. (3-Aralkylamino-2-or-propoxy) heterocyclic compounds
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
DE4029807A1 (de) * 1990-09-20 1992-03-26 Bayer Ag 4-amino-3-hydroxy-phthalid, sowie ein verfahren zu seiner herstellung
DE4426373A1 (de) * 1994-07-26 1996-02-01 Bayer Ag 3-Substituierte Chinolin-5-carbonsäurederivate und Verfahren zu ihrer Herstellung
WO2004050657A2 (fr) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. Composes presentant une activite mixte d'inhibition de la pde et d'antagoniste ou d'agoniste partiel ?eta-adrenergique pour traiter l'insuffisance cardiaque

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011321A (en) * 1973-12-19 1977-03-08 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting β-adrenergic receptors

Also Published As

Publication number Publication date
FR2340310B1 (fr) 1980-03-07
GB1567907A (en) 1980-05-21
DE2705414A1 (de) 1977-08-11
US4093725A (en) 1978-06-06
JPS5297986A (en) 1977-08-17
BE851237A (fr) 1977-08-09

Similar Documents

Publication Publication Date Title
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE847368A (fr) Nouvelles compositions pharmaceutiques et leur preparation,
BE888389A (fr) Acrylamido-cephalosporines omega, beta-disubstituees leur preparation et compositions pharmaceutiques en contant,
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
BE848227A (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant,
FR2320745A1 (fr) Nouveaux agents anti-flammatoires imidazoles, leur preparation et compositions pharmaceutiques
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
BE871857A (fr) Nouvelles piperazines disubstituees, leur procedes de preparation et les compositions pharmaceutiques les renfermant
BE872956A (fr) Polyfluorohydroxyisopropyl carbostyriles bicycliques et tricycliques antihypertensifs,leur preparation et compositions pharmaceutiques les contenant
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
BE806854A (fr) Nouvelles urees tricycliques, leur preparation et les compositions pharmaceutiques en contenant
LU81182A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent
FR2313059A1 (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
BE843115A (fr) Compositions pharmaceutiques contenant de la debrycine heterocolloidale et leur procede de preparation
BE892635A (fr) Mercapto acyl-carnitines, leur preparation et compositions pharmaceutiques en contenant
BE872955A (fr) Composes polyfluorohydroxyisopropyl carbostyriles tricycliques antihypertensifs, leur preparation et compositions pharmaceutiques les contenant
FR2283670A1 (fr) Derives d'acides 19,20-bis-nor-prostanoique, leur preparation et compositions pharmaceutiques les contenant
BE869834A (fr) Nouveaux derives de 3-amino-17a-aza-d-homo-androstane, leur procede de preparation et les compositions pharmaceutiques les contenant
BE848385A (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant,
BE860126A (fr) Derives de 4,6-di-o-(aminoglycosyl)-1,3-diamino-cyclitols leur procede de preparation et compositions pharmaceutiques les contenant
FR2291758A1 (fr) Nouvelles benzodiazepines, leur preparation et medicament les contenant
BE854046A (fr) Arylurees substituees, leur procede de preparation et compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
ST Notification of lapse